These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 36855123)
1. Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP. Gao Y; Yuan L; Ke C; Pei Z; Liu X; Wu R; Kui X; Zhang Y J Transl Med; 2023 Feb; 21(1):159. PubMed ID: 36855123 [TBL] [Abstract][Full Text] [Related]
2. eIF6 is potential diagnostic and prognostic biomarker that associated with Gao Y; Yuan L; Zeng J; Li F; Li X; Tan F; Liu X; Wan H; Kui X; Liu X; Ke C; Pei Z J Transl Med; 2022 Jul; 20(1):303. PubMed ID: 35794622 [TBL] [Abstract][Full Text] [Related]
3. High expression of HNRNPR in ESCA combined with Liu XY; Gao Y; Kui XY; Liu XS; Zhang YH; Zhang Y; Ke CB; Pei ZJ J Transl Med; 2022 Oct; 20(1):450. PubMed ID: 36195940 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of METTL3 associated with the metabolic status on Liu XS; Yuan LL; Gao Y; Zhou LM; Yang JW; Pei ZJ J Cancer; 2020; 11(16):4851-4860. PubMed ID: 32626532 [No Abstract] [Full Text] [Related]
5. SPDL1 Overexpression Is Associated With the 18F-FDG PET/CT Metabolic Parameters, Prognosis, and Progression of Esophageal Cancer. Liu HS; Guo Q; Yang H; Zeng M; Xu LQ; Zhang QX; Liu H; Guo JL; Zhang J Front Genet; 2022; 13():798020. PubMed ID: 35664322 [TBL] [Abstract][Full Text] [Related]
6. METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Liu XS; Zhang Y; Liu ZY; Gao Y; Yuan LL; Zeng DB; Tan F; Wan HB; Pei ZJ J Cell Mol Med; 2024 Mar; 28(6):e18195. PubMed ID: 38429907 [TBL] [Abstract][Full Text] [Related]
7. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
8. Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma. Liu XS; Liu ZY; Zeng DB; Hu J; Chen XL; Gu JL; Gao Y; Pei ZJ Aging (Albany NY); 2024 Feb; 16(4):3934-3954. PubMed ID: 38382106 [TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability. Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572 [TBL] [Abstract][Full Text] [Related]
10. Kinesin family member 23 knockdown inhibits cell proliferation and epithelial-mesenchymal transition in esophageal carcinoma by inactivating the Wnt/β-catenin pathway. Xu Q; Li X; Li Y; Yu J; Yang A Funct Integr Genomics; 2023 May; 23(2):154. PubMed ID: 37162618 [TBL] [Abstract][Full Text] [Related]
11. High expression of WTAP is related to poor prognosis in nasopharyngeal carcinoma. Tao CJ; Zhang P; Chen YY; Chen M Neoplasma; 2023 Apr; 70(2):229-239. PubMed ID: 36964720 [TBL] [Abstract][Full Text] [Related]
12. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751 [TBL] [Abstract][Full Text] [Related]
13. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma. Zhang Y; Zhang J; Pan G; Guan T; Zhang C; Hao A; Li Y; Ren H World J Surg Oncol; 2021 Aug; 19(1):242. PubMed ID: 34399788 [TBL] [Abstract][Full Text] [Related]
14. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data. Li D; Deng W; Huang G; Xiao X Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339 [TBL] [Abstract][Full Text] [Related]
15. PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways. Feng AL; Han X; Meng X; Chen Z; Li Q; Shu W; Dai H; Zhu J; Yang Z Clin Transl Oncol; 2020 Oct; 22(10):1838-1848. PubMed ID: 32130676 [TBL] [Abstract][Full Text] [Related]
16. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961 [TBL] [Abstract][Full Text] [Related]
17. Rhein suppresses esophageal cancer development by regulating cell cycle through DNMT3B gene. Li C; Yu J; Feng Y; Sun X; Sun M; Ni W; Shao J; Wang B Med Oncol; 2024 May; 41(6):153. PubMed ID: 38743323 [TBL] [Abstract][Full Text] [Related]
18. WTAP Targets the METTL3 m Sacco MT; Bland KM; Horner SM J Virol; 2022 Nov; 96(22):e0099722. PubMed ID: 36314819 [TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK). Wang B; Zhang L; Li J; Hua P; Zhang Y Dig Dis Sci; 2020 Oct; 65(10):2853-2862. PubMed ID: 31894485 [TBL] [Abstract][Full Text] [Related]
20. CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population. Xu H; Yang Z; Hu W; Zhou X; Zhang Z; Zhang X BMC Cancer; 2024 Jun; 24(1):729. PubMed ID: 38877481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]